Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Precigen

Biotech & Life Sciences · Germantown, United States · Founded 1998 · IPO 2013 Unicorn

Biologically-based products that improve the quality of life and the health of the planet

Valuation
$1.47B
Market cap · May/2026
Revenue
$9.7M
Latest reported FY

Investors

2 investors on Precigen's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 2 investors entered at this stage
NewVa Capital Partners
Third Security LLC

Global footprint

Where Precigen has talent and traffic

Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown
Web traffic by country
5.8K monthly visits
across markets
🇺🇸 United States75.9%
🇮🇳 India24.1%
Top 2 markets shown

Patent intelligence

$86M patent portfolio · 58 active families

Estimated portfolio value
$86M
5.9% of market cap · 4.3× smaller than top peer Translate Bio ($371M)
58 active patent families
Where Precigen innovates Molecular biologyMicrobiologyMicroorganismDrugHeterologous

Where Precigen concentrates vs peers

Each axis is a top-10 topic across Precigen and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Precigen's 3 investments and acquisitions.

Every disclosed deal where Precigen appeared as a backer or acquirer, 2015–2017. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

3 deals across Precigen's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        Precigen's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        3 of 3 deals

        Market sentiment

        What the market is saying about Precigen

        An AI-synthesized read of the highest-engagement posts about Precigen on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Precigen on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.